BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 20923277)

  • 1. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.
    De Bruyn C; Najar M; Raicevic G; Meuleman N; Pieters K; Stamatopoulos B; Delforge A; Bron D; Lagneaux L
    Stem Cells Dev; 2011 Mar; 20(3):547-57. PubMed ID: 20923277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
    Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
    Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.
    Margossian T; Reppel L; Makdissy N; Stoltz JF; Bensoussan D; Huselstein C
    Biomed Mater Eng; 2012; 22(4):243-54. PubMed ID: 22785368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
    Fong CY; Subramanian A; Biswas A; Bongso A
    J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells.
    Roy S; Arora S; Kumari P; Ta M
    Cryobiology; 2014 Jun; 68(3):467-72. PubMed ID: 24704519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
    Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
    Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
    Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
    Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.
    Xu Y; Huang S; Ma K; Fu X; Han W; Sheng Z
    J Tissue Eng Regen Med; 2012 Aug; 6(8):645-54. PubMed ID: 21916019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunologic and hematopoietic profiles of mesenchymal stem cells derived from different sections of human umbilical cord.
    Xu M; Zhang B; Liu Y; Zhang J; Sheng H; Shi R; Liao L; Liu N; Hu J; Wang J; Ning H; Liu T; Zhang Y; Chen H
    Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1056-65. PubMed ID: 25377438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
    Nekanti U; Rao VB; Bahirvani AG; Jan M; Totey S; Ta M
    Stem Cells Dev; 2010 Jan; 19(1):117-30. PubMed ID: 19619003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
    Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
    Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of biological characteristics and advantages of Wharton's jelly-mesenchymal stem cells].
    Liu L; Chai J; Han Y; Sun T; Li D; Zhao J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):745-9. PubMed ID: 21735792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
    Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
    Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.